Abstract:Type I interferons (IFNs) play essential roles in establishing and modulating host defense against microbial infection via induction of IFN-stimulated genes (ISGs) through Janus kinase (JAK)–signal transducer and activator of transcription (STAT) signaling pathway. However, dysregulation of IFNs production and function could also mediate immune pathogenesis such as inflammatory autoimmune diseases and infectious diseases via aberrantly activating inflammatory responses or improperly suppressing microbial controls. Thus, IFN responses need to be tightly regulated to achieve protective immunity against microbial infection while avoiding harmful toxicity caused by improper or prolonged IFN signaling. Multiple levels of cellular and molecular events act in a cooperated manner to regulate IFN responses, in especial, post-translational modification (PTMs) of signaling molecules and epigenetic modification of gene expression programs are two important mechanisms for regulation of IFN signaling and thus critical for orchestrating IFN-mediated host immune response to the complex pathogenic or environmental stimuli. Conventional PTMs such as phosphorylation and polyubiquitylation, as well as numerous other PTMs including acetylation, ISGylation, SUMOylation and methylation have been shown to potently modulate type I IFN signaling transduction via targeting distinct signaling steps or components. Moreover, epigenetic mechanisms, such as histone modification, DNA methylation, non-coding RNAs play critical roles in regulating chromatin structure and function, leading to flexible and dynamic gene expression patterns downstream type I IFN signaling. Herein, we summarize the recent advances in the PTMs and epigenetic mechanisms in regulation of type I IFN signaling and responses. The involvement of dysregulated IFN signaling in inflammatory and autoimmune diseases are also discussed.

Transcriptional and posttranslational regulation of Th17/Treg balance in health and disease

The Functional Stability of FOXP3 and RORγt in Treg and Th17 and Their Therapeutic Applications.

FOXP3 and RORγt: transcriptional regulation of Treg and Th17.

Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review

Research Advance of Regulative Mechanism for TH17 Differentiation

The Balance of Intestinal Foxp3+regulatory T Cells and Th17 Cells and Its Biological Significance

The Balance of Th17 versus Treg Cells in Autoimmunity

Improving regulatory T cell-based therapy: insights into post-translational modification regulation

Transcriptional Regulation of Early T-Lymphocyte Development in Thymus

Negative Regulation of TH17 Differentiation

Progress in The Differentiation, Regulation and Function of Th17 Lineage

Research Progress on Regulatory T Cells and Their Relationship with Autoimmune Diseases

Control of Regulatory T Cells and T Helper Cells in Human Diseases: from Bench to Bedside.

Th17/Treg Imbalance: Implications in Lung Inflammatory Diseases

The Research Progress of Th17 Cells and Treg Cells in Regulating Tumor Immunity

The Progress and Prospect of Regulatory T Cells in Autoimmune Diseases

Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications

Foxp3, Regulatory T Cell, and Autoimmune Diseases

Gut microbiota contributes to the intestinal and extraintestinal immune homeostasis by balancing Th17/Treg cells

The functional regulation of Treg and its role in anti-tumor immunotherapy

Therapeutic Potential of TGF-β-induced CD4+ Foxp3+ Regulatory T Cells in Autoimmune Diseases